Gene Query: CUEDC2

Dataset Description Geneva Score
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 27.47
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 20.76
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 17.58
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 15.54
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 14.21
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 14.11
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 14.11
Survival of pancreatic cancer cells lacking KRAS function 13.86
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 13.36
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.28
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.11
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 11.88
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 11.54
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 11.48
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.31
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 11.13
Genome wide expression change in LCC2 and MCF-7 cells 11.07
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 11.0
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.66
Impact of dieldrin on transcription in Jurkat T cells 10.48
Gene expression profiling of leukemia cells following asparagine depletion 10.18
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 10.02
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.94
The regulartory role of ZCCHC24 in splicing machinery 9.87
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 9.56
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 9.32
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.08
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 8.75
Transcriptomic analysis of human tonsillar TFH subsets 8.74
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.69
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.66
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 8.46
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 8.46
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 8.45
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.4
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.35
Effect of disulfiram treatment on pediatric high grade glioma 8.31
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 8.25
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.23
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.21
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 8.2
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.09
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 8.04
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 7.89
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.85
scRNASeq analysis of cycling cardiomyocytes 7.61
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 7.61
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.55
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 7.51
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.5
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 7.49
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.39
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.17
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 7.12
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.12
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.12
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.97
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.97
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.93
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.93
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.92
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 6.81
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 6.81
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 6.8
AR-independent prostate cancer is sustained through FGF signaling 6.78
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 6.74
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.72
The comparison of high-throughput single-cell RNA-seq methods 6.72
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.68
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 6.64
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.62
CROP-Seq in Primary Human T Cells 6.61
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.6
IDH3a KO RNA-seq 6.59
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.56
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.51
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 6.49
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.45
Stem and effector CD8 T-cells from human cancers 6.42
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.42
N6-methyladenine DNA Modification in Glioblastoma 6.42
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.4
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 6.38
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 6.34
Identification of long noncoding RNAs regulated by p53 6.21
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.2
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.2
Aneuploidy triggers an immune response 6.18
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.11
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 6.09
Transcriptome analysis of Zika infected neural stem cells 6.08
Zika infected neural stem cells 6.08
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.0
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 5.98
METTL3 promotes translation in human cancer cells 5.96
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.95
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.95
SRSF2 mutations impair hematopoiesis and alter exon recognition 5.94
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.86
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.86
Gene expression changes due to PARP knockdown in human cells 5.84
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.84
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 5.82
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.81
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 5.76
RNA editing in nascent RNA affects pre-mRNA splicing 5.75
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 5.73
hTERT promotes cell adhesion and migration independent of telomerase activity 5.65
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 5.64
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 5.64
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.59
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.58
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.51
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.5
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 5.49
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 5.49
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.49
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.48
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 5.44
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 5.44
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 5.43
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 5.39
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 5.39
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 5.38
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 5.36
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 5.35
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 5.34
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 5.32
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.29
HEK293 TFAM Knockout Expression Study 5.29
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.25
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.23
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 5.21
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 5.21
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.21
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 5.19
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 5.18
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.18
Human Treg IL-12 stimulation 5.15
Gene expression changes after LOC550643 silencing 5.14
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.11
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 5.08
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 5.08
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.06
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.06
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.05
miRNAs affected by antagomiR-17 treatment 5.04
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 5.04
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 5.01
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 5.01
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.01
RNA-seq analysis of uveal melanoma cells treated with FR900359 4.99
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 4.99
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.97
Global analysis of enhancer targets: Mosaic-seq 4.95
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.94
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 4.9
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 4.9
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.87
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.87
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.84
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 4.81
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.8
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.8
snRNAs as regulators of alternative splicing 4.79
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.78
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.78
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.73
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 4.71
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 4.71
Co-transcriptional loading of RNA export factors shapes the human transcriptome 4.69
RNAseq of HEK293 cells after Chtop knockdown 4.69
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.68
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 4.61
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 4.59
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.58
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.58
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.58
Lipid degradation promotes prostate cancer cell survival 4.57
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.57
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.57
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.57
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.56
Accurate annotation of human protein-coding small open reading frames 4.55
Transcriptome analysis of U87 cells upon LINC00152 knockdown 4.52
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.51
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.51
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 4.49
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 4.48
Co-regulation of splicing by Rbfox1 and hnRNP M 4.46
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.46
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.45
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.45
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 4.45
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.44
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.43
Genome-wide functional assessment of enhancer activities in the human genome 4.42
TT-Seq captures the human transient transcriptome 4.38
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.38
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.38
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.38
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 4.34
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.34
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 4.33
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.3
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.3
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.28
RNA-seq of IL-4 stimulated human keratinocytes 4.27
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.27
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 4.21
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.2
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.2
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.18
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 4.17
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 4.17
Transcriptome of U251 cells overexpression complement component 7 4.14
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.14
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.12
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.12
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 4.11
Single-cell analysis of adult human ovary using 10X genomics 4.09
T47D RNA-seq and ChrRNA-seq data 4.06
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.06
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.0
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 4.0
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.99
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.99
RNA sequencing of human mammary epithelial cells 3.97
STRIPAK directs PP2A activity to promote oncogenic transformation 3.95
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.93
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.93
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.89
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.88
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.88
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.87
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 3.84
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.83
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.81
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.8
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 3.8
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 3.8
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 3.77
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 3.76
Gene expression in GBM with Cav3.2 inhibition 3.74
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 3.73
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 3.72
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.71
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.7
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.67
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.67
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 3.65
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.65
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.58
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.57
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.52
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.51
RNA-seq analysis of the human fetal kidney. 3.48
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.47
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.44
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.44
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.42
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.41
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.41
Transcriptional effect of ETV1 knockdown in melanoma cells 3.41
RNAseq of T-ALL upon long non coding rna purturbation 3.4
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 3.39
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 3.38
Activity-dependent transcriptional changes in human neurons 3.33
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.32
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 3.27
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 3.25
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.22
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.21
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.2
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.19
Total RNA sequencing of APC mutant and wt colonic organoids 3.19
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.17
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 3.14
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.12
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 3.11
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.1
RNA-sequencing in immortalized human mammary epithelial cells 3.1
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 3.04
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.01
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.94
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.94
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.93
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.9
Gene expression signatures of innate lymphoid cells from human blood 2.9
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.89
The DPYSL2 gene connects mTOR and schizophrenia 2.86
Controlling for gene expression changes in transcription factor protein networks. 2.86
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.86
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.83
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.81
Androgen Receptor-regulated genes in prostate cancer cells 2.81
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.8
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.8
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.77
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.77
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.77
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.76
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.76
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.76
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.74
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.73
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.7
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.66
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.64
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.6
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.6
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 2.6
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.6
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.6
Transciptomic profiling of human fetal lung samples 2.57
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.51
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.45
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.44
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.42
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.41
X-Ray induced DNA-Hydroxymethylation changes 2.4
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.36
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.32
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 2.29
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 2.28
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.26
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.26
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.23
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.2
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.2
RNAseq of cell lines with knocked in ESR1 mutations 2.19
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.19
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.19
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.18
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.12
H1609088 Human RNA-Sequencing 2.07
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.07
mRNA recovered upon RNF219 IP. [RNA-IP] 2.07
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.05
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.01
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 2.0
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.0
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.98
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.98
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.98
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.97
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.97
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.96
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.94
Regulatory network controlling tumor-promoting inflammation in human cancers 1.94
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.92
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.92
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.91
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.91
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.91
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.87
Total RNA sequencing of WT intestinal orgaonids. 1.86
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.82
Triple vectors expand AAV transfer capacity in the retina 1.77
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.76
Effect of PBK knockdown on C4-2 cell transcriptome 1.75
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.75
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.74
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.74
Transcriptome analysis of SKI knock-out in HL60 cells 1.73
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.73
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.72
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 1.71
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.7
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.7
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.68
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.66
Single-cell analysis of human kidney organoids 1.66
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.66
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.66
Transcriptome sequencing of K-562 cells 1.64
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.63
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.63
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.6
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.59
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.59
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.58
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.57
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.57
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.56
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.53
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.53
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.51
RNA-sequencing of healthy human skeletal myocytes 1.5
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.48
Ribosomal protein RPL26 is the principal target of UFMylation 1.48
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 1.43
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.41
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.41
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.39
Discovering human diabetes-risk gene function with genetics and physiological assays 1.39
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.37
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 1.37
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 1.37
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.34
Human Treg NaCl stimulation 1.34
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.34
AUF-1 affected genes in human skin cells 1.32
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.32
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.31
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.3
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.29
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.25
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.24
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.2
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.19
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.18
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.18
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.15
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.14
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.14
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.14
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.14
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.02
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.99
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.99
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.97
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.96
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.95
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.95
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.95
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.95
Functional significance of the HIV-1 Tat signature amino acid residues 0.93
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.92
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.91
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.9
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.9
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.87
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.86
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.86
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.85
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.85
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.76
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.76
Copper Regulation of HIF-1 Transcription Activity 0.75
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.75
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.74
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.72
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.71
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.7
Comparative Analysis of Cas9 Activators Across Multiple Species 0.63
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 0.6
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.59
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.58
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.52
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.51
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.51
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.48
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.47
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.46
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.44
A code of mono-phosphorylation modulates the function of RB. 0.43
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.42
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.41
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.41
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.41
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.41
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.4
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.38
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.37
Role of FGFR1 in neuronal devlopment 0.37
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.36
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.31
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 0.3
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.29
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.27
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.27
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.25
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.25
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.23
An optimization system for isolating and sequencing of single human colon cancer cells 0.2
Impact on erythroid progenitor type on erythroid differntiation 0.17
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.17
Induced DNA demethylation, genome instability and transcription 0.17
Function and hormonal regulation of GATA3 in human first trimester placentation 0.17
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.17
Effects of transcription on genome - nuclear lamina interactions 0.17
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.16
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.15
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.14
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.14
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.13
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.12
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.11
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.07
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.07
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.07
Metabolism as an early predictor of DPSCs aging 0.05
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.04
The contribution of Alu exons to the human proteome 0.04
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.04
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation